Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,776 | 813 | 99.1% |
| Education | $123.59 | 10 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,804 | 108 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,499 | 63 | $0 (2024) |
| ABBVIE INC. | $1,328 | 63 | $0 (2024) |
| Lilly USA, LLC | $988.55 | 73 | $0 (2024) |
| PFIZER INC. | $828.27 | 73 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $812.04 | 64 | $0 (2021) |
| Allergan, Inc. | $630.83 | 61 | $0 (2020) |
| Astellas Pharma US Inc | $602.36 | 27 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $532.21 | 31 | $0 (2023) |
| Amgen Inc. | $531.51 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,676 | 73 | ABBVIE INC. ($209.98) |
| 2023 | $1,247 | 63 | ABBVIE INC. ($217.23) |
| 2022 | $900.66 | 49 | ABBVIE INC. ($341.71) |
| 2021 | $2,577 | 140 | AbbVie Inc. ($559.05) |
| 2020 | $1,442 | 88 | AstraZeneca Pharmaceuticals LP ($398.22) |
| 2019 | $2,141 | 140 | Novo Nordisk Inc ($351.06) |
| 2018 | $2,025 | 148 | Janssen Pharmaceuticals, Inc ($238.20) |
| 2017 | $1,891 | 122 | Novo Nordisk Inc ($263.32) |
All Payment Transactions
823 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: VACCINES | ||||||
| 10/30/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.14 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Cardio-renal | ||||||
| 10/03/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Insomnia | ||||||
| 09/25/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $111.32 | General |
| Category: Insomnia | ||||||
| 09/25/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: VACCINES | ||||||
| 08/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $121.83 | General |
| 08/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Diabetes Care | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Respiratory | ||||||
| 07/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,106 | 1,615 | $242,146 | $104,017 |
| 2022 | 17 | 959 | 1,357 | $187,080 | $81,619 |
| 2021 | 18 | 1,058 | 1,341 | $217,024 | $99,338 |
| 2020 | 18 | 955 | 1,232 | $182,605 | $73,509 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 256 | 421 | $77,464 | $34,691 | 44.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 213 | 213 | $57,297 | $25,707 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 221 | 295 | $37,170 | $13,827 | 37.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 89 | $15,931 | $7,973 | 50.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 43 | 49 | $17,101 | $6,272 | 36.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 51 | 58 | $7,830 | $3,450 | 44.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Office | 2023 | 22 | 36 | $6,444 | $3,280 | 50.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 44 | 44 | $3,524 | $3,214 | 91.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 48 | 48 | $1,488 | $1,392 | 93.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 22 | 46 | $4,508 | $1,338 | 29.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 23 | 27 | $6,966 | $964.00 | 13.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 53 | 104 | $3,224 | $922.58 | 28.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 16 | $1,984 | $921.84 | 46.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 22 | 50 | $200.00 | $48.90 | 24.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 20 | 98 | $490.00 | $9.13 | 1.9% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 11 | 21 | $525.00 | $7.34 | 1.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 180 | 180 | $48,420 | $22,766 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 251 | 359 | $45,234 | $19,008 | 42.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 145 | 200 | $36,800 | $15,550 | 42.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 41 | 92 | $16,468 | $7,380 | 44.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 31 | $10,819 | $4,841 | 44.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 48 | 48 | $3,216 | $3,153 | 98.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 40 | $4,960 | $2,240 | 45.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 31 | 35 | $4,725 | $1,929 | 40.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 49 | 49 | $1,517 | $1,340 | 88.3% |
About Dr. Juan Perez Ruiz, MD
Dr. Juan Perez Ruiz, MD is a Internal Medicine healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821106261.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Juan Perez Ruiz, MD has received a total of $13,899 in payments from pharmaceutical and medical device companies, with $1,676 received in 2024. These payments were reported across 823 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($13,776).
As a Medicare-enrolled provider, Perez Ruiz has provided services to 4,078 Medicare beneficiaries, totaling 5,545 services with total Medicare billing of $358,483. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Lafayette, LA
- Active Since 08/27/2006
- Last Updated 11/19/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1821106261
Products in Payments
- Ozempic (Drug) $923.79
- FARXIGA (Drug) $805.40
- UBRELVY (Drug) $741.33
- XARELTO (Drug) $600.77
- VRAYLAR (Drug) $501.19
- TRULICITY (Drug) $427.90
- QULIPTA (Drug) $360.83
- MOUNJARO (Drug) $331.94
- REXULTI (Drug) $276.93
- Kerendia (Drug) $272.54
- JARDIANCE (Drug) $270.10
- SHINGRIX (Biological) $264.20
- Vascepa (Drug) $263.90
- XIFAXAN (Drug) $252.25
- MYRBETRIQ (Drug) $229.26
- ELIQUIS (Drug) $224.36
- BREZTRI (Drug) $223.61
- TRINTELLIX (Drug) $217.86
- INVOKANA (Drug) $211.27
- RYBELSUS (Drug) $207.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lafayette
Steven Steinhubl, Md, MD
Internal Medicine — Payments: $172,128
Dr. Eric Trawick, Md, MD
Internal Medicine — Payments: $83,507
Dr. Brent Rochon, Md, MD
Internal Medicine — Payments: $23,953
Hector Robles, Md, MD
Internal Medicine — Payments: $23,742
Dr. Robert Russell, Md, MD
Internal Medicine — Payments: $18,283
Nethuja Salagundla, M.d, M.D
Internal Medicine — Payments: $17,501